Jan 6, 2024
Really interesting. I guess the news isn't widespread because of the points you touched on, primarily that this drug wouldn't benefit the pharmaceutical companies.
Really interesting. I guess the news isn't widespread because of the points you touched on, primarily that this drug wouldn't benefit the pharmaceutical companies.
Writer, editor, publisher, journalist, author, columnist, former nonprofit director. bknicholson@att.net